Vanguard Group Inc Cytom X Therapeutics, Inc. Transaction History

Vanguard Group Inc

  • $5.37 Trillion
  • Q1 2025

A detailed history of Vanguard Group Inc transactions in Cytom X Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 5,117,376 shares of CTMX stock, worth $10.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,117,376
Previous 5,162,302 0.87%
Holding current value
$10.8 Million
Previous $5.32 Million 38.41%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025
SELL
$0.58 - $1.14 $26,057 - $51,215
-44,926 Reduced 0.87%
5,117,376 $3.28 Million
Q3 2024

Nov 13, 2024
BUY
$1.12 - $1.51 $302,400 - $407,700
270,000 Added 5.52%
5,162,302 $6.09 Million
Q2 2024

Aug 13, 2024
BUY
$1.21 - $5.13 $42,262 - $179,180
34,928 Added 0.72%
4,892,302 $5.97 Million
Q1 2024

May 10, 2024
SELL
$1.41 - $2.74 $64,252 - $124,859
-45,569 Reduced 0.93%
4,857,374 $10.6 Million
Q2 2023

Aug 14, 2023
SELL
$1.41 - $1.92 $17,075 - $23,251
-12,110 Reduced 0.25%
4,902,943 $8.43 Million
Q1 2023

May 15, 2023
BUY
$1.48 - $2.88 $487,411 - $948,476
329,332 Added 7.18%
4,915,053 $7.42 Million
Q4 2022

Feb 10, 2023
BUY
$1.19 - $1.91 $56,834 - $91,221
47,760 Added 1.05%
4,585,721 $7.34 Million
Q3 2022

Nov 14, 2022
SELL
$1.23 - $1.97 $664,723 - $1.06 Million
-540,426 Reduced 10.64%
4,537,961 $6.58 Million
Q2 2022

Aug 12, 2022
SELL
$1.53 - $2.89 $221,083 - $417,602
-144,499 Reduced 2.77%
5,078,387 $9.29 Million
Q1 2022

May 13, 2022
BUY
$2.67 - $4.68 $306,769 - $537,708
114,895 Added 2.25%
5,222,886 $13.9 Million
Q4 2021

Feb 14, 2022
SELL
$3.87 - $7.39 $1.58 Million - $3.02 Million
-408,330 Reduced 7.4%
5,107,991 $22.1 Million
Q3 2021

Nov 12, 2021
BUY
$4.32 - $6.43 $683,579 - $1.02 Million
158,236 Added 2.95%
5,516,321 $28.1 Million
Q2 2021

Aug 13, 2021
BUY
$6.33 - $9.91 $33.9 Million - $53.1 Million
5,358,085 New
5,358,085 $33.9 Million

Others Institutions Holding CTMX

# of Institutions
66
Shares Held
44.1M
Call Options Held
8.9K
Put Options Held
47.9K
View Full List

About CytomX Therapeutics, Inc.

CTMX Quotes by TradingView
  • Ticker CTMX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,950,200
  • Market Cap $140M
  • Description
  • CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...
More about CTMX
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email